Results 161 to 170 of about 12,126 (208)

Fusobacterium nucleatum-Derived Outer Membrane Vesicles Disrupt Epithelial Barrier in Oral Lichen Planus via JNK/c-JUN Mediated Claudin-4 Downregulation. [PDF]

Int Dent J
Shao R, Wang Z, Yang C, Chen J, Du G.
europepmc   +1 more source

Rapid resolution of refractory cutaneous lichen planus with abrocitinib. [PDF]

JAAD Case Rep
Ho A, Goldberg R, Hamann CR.
europepmc   +1 more source

Assessment of Different Treatment Modalities for the Treatment of Oral Lichen Planus.

J Pharm Bioallied Sci
Basu S, Srivastava S, Sinha Α, Srivastava A, Mishra A, Iqbal H, Sethi KK, Srivastava S, Yadav A.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Oral Lichen Planus

Oral and Maxillofacial Surgery Clinics of North America, 2013
Oral lichen planus is a common immunologically mediated mucocutaneous disease. These lesions have varied clinical presentations and symptoms, which include reticular, erosive, or erythematous forms. This article reviews the diagnosis and management of oral lichen planus.
Justin, Au, Dhaval, Patel, John H, Campbell   +2 more
exaly   +3 more sources

Oral Lichen Planus

Primary Dental Journal, 2016
Lichen planus (LP) is a relatively common autoimmune T-cell-mediated disease of unknown aetiology affecting the mucous membranes, skin and nails. Its prevalence varies between 0.5 and 2.2% of the population in epidemiological studies with a peak incidence in the 30–60 years range and with a female predominance of 2:1.
Daniela I, Ion, Jane F, Setterfield
  +6 more sources